Terns Pharmaceuticals, Inc. (TERN)
42.42
+0.89
(+2.14%)
USD |
NASDAQ |
Dec 24, 12:59
Terns Pharmaceuticals SG&A Expense (TTM): 31.48M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Rhythm Pharmaceuticals, Inc. | 175.59M |
| Altimmune, Inc. | 22.68M |
| ADMA Biologics, Inc. | 96.37M |
| Viking Therapeutics, Inc. | 52.36M |
| Arcellx, Inc. | 110.28M |